Eleven Biotherapeutics reported $-825000 in EBITDA for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Amgen AMGN:US $ 3341M 185M
Bristol Myers Squibb BMY:US $ 5772M 404M
Corcept Therapeutics CORT:US $ 27.06M 9.9M
Eleven Biotherapeutics EBIO:US $ -0.82M 9.8M
Eli Lilly And LLY:US $ 3005.6M 161.6M
Intrexon XON:US $ -14.12M 3.05M
Merk MRK:US $ 6179M 492M
Pfizer PFE:US $ 11182M 4046M
Rigel Pharmaceuticals RIGL:US $ -26.02M 8.53M
Ziopharm Oncology ZIOP:US $ -8.4M 1.21M